儿童和成人偏头痛的现状

Abigail L. Chua, B. Grosberg, R. Evans
{"title":"儿童和成人偏头痛的现状","authors":"Abigail L. Chua, B. Grosberg, R. Evans","doi":"10.1111/head.13676","DOIUrl":null,"url":null,"abstract":"According to the International Classification of Headache Disorders, 3rd edition (ICHD-3), status migrainosus (SM) is “a debilitating migraine attack lasting for more than 72 hours.” Analogous to the term “status epilepticus,” “status migrainosus” was coined by Taverner in 1975, used by Lance in 1978, and was first added to the International Classification of Headache Disorders (ICHD-1) in 1988. The condition occurs in those with migraine with or without aura and, aside from increased duration and severity, has features similar to the individual's prior migraine attacks. While attacks should last greater than 72 hours to fulfill the diagnostic criteria for SM (Table 1), short periods of remission (less than 12 hours) due to medication or sleep are accepted. CASE HISTORY This is a 31-year-old woman with a history of migraine without aura for 5 years occurring twice a month lasting 1-2 hours after taking 10 mg of rizatriptan. She presented to the office with an exactly similar nonmenstrual headache continuously occurring for 5 days associated with increased stress and lack of sleep. The headache is described as a generalized, especially bifrontal-temporal, throbbing pain associated with nausea, light and noise sensitivity but no vomiting or aura. Pain intensity was initially 3/10 and since onset has been ranging from 3-8/10; at presentation to the office, her headache severity was 7/10. She had tried rizatriptan, ibuprofen, and a combination of acetaminophen (APAP) /aspirin/caffeine for the past 4 days without help. Past medical history was negative. Neurological exam was normal and she denied any recent illness, trauma, or change in medications. She was given bilateral greater occipital nerve (GON) blocks with 3 cc each and bilateral auriculotemporal, supraorbital, and supratrochlear nerve blocks with 0.5 cc each of 1% lidocaine, as well as diclofenac sodium 50 mg oral solution with resolution of the headache.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"27 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Status Migrainosus in Children and Adults\",\"authors\":\"Abigail L. Chua, B. Grosberg, R. Evans\",\"doi\":\"10.1111/head.13676\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"According to the International Classification of Headache Disorders, 3rd edition (ICHD-3), status migrainosus (SM) is “a debilitating migraine attack lasting for more than 72 hours.” Analogous to the term “status epilepticus,” “status migrainosus” was coined by Taverner in 1975, used by Lance in 1978, and was first added to the International Classification of Headache Disorders (ICHD-1) in 1988. The condition occurs in those with migraine with or without aura and, aside from increased duration and severity, has features similar to the individual's prior migraine attacks. While attacks should last greater than 72 hours to fulfill the diagnostic criteria for SM (Table 1), short periods of remission (less than 12 hours) due to medication or sleep are accepted. CASE HISTORY This is a 31-year-old woman with a history of migraine without aura for 5 years occurring twice a month lasting 1-2 hours after taking 10 mg of rizatriptan. She presented to the office with an exactly similar nonmenstrual headache continuously occurring for 5 days associated with increased stress and lack of sleep. The headache is described as a generalized, especially bifrontal-temporal, throbbing pain associated with nausea, light and noise sensitivity but no vomiting or aura. Pain intensity was initially 3/10 and since onset has been ranging from 3-8/10; at presentation to the office, her headache severity was 7/10. She had tried rizatriptan, ibuprofen, and a combination of acetaminophen (APAP) /aspirin/caffeine for the past 4 days without help. Past medical history was negative. Neurological exam was normal and she denied any recent illness, trauma, or change in medications. She was given bilateral greater occipital nerve (GON) blocks with 3 cc each and bilateral auriculotemporal, supraorbital, and supratrochlear nerve blocks with 0.5 cc each of 1% lidocaine, as well as diclofenac sodium 50 mg oral solution with resolution of the headache.\",\"PeriodicalId\":12845,\"journal\":{\"name\":\"Headache: The Journal of Head and Face Pain\",\"volume\":\"27 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Headache: The Journal of Head and Face Pain\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/head.13676\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Headache: The Journal of Head and Face Pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/head.13676","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

根据国际头痛疾病分类第三版(ICHD-3),偏头痛状态(SM)是“持续72小时以上的衰弱性偏头痛发作”。与“癫痫持续状态”类似,“偏头痛状态”一词由Taverner于1975年创造,Lance于1978年使用,并于1988年首次加入国际头痛疾病分类(ICHD-1)。这种情况发生在有或没有先兆的偏头痛患者身上,除了持续时间和严重程度增加外,其特征与个人先前的偏头痛发作相似。虽然发作应持续72小时以上才能满足SM的诊断标准(表1),但由于药物或睡眠导致的短时间缓解(少于12小时)是可以接受的。病例史:31岁女性,5年无先兆偏头痛病史,服用10mg利扎曲坦后每月2次,持续1-2小时。她到办公室时出现了完全相同的非经期头痛,持续了5天,并伴有压力增加和睡眠不足。头痛被描述为一种全身性,特别是双额颞叶,悸动性疼痛,伴有恶心,对光和噪音敏感,但无呕吐或先兆。疼痛强度最初为3/10,自发病以来一直在3-8/10之间变化;到办公室就诊时,她的头痛严重程度为7/10。在过去的4天里,她尝试了利扎曲坦、布洛芬和对乙酰氨基酚/阿司匹林/咖啡因的组合,但没有任何帮助。既往病史为阴性。神经系统检查正常,她否认近期有任何疾病、创伤或药物变化。给予双侧枕大神经(GON)阻滞3cc,双侧耳颞、眶上和滑车上神经阻滞0.5 cc, 1%利多卡因,双氯芬酸钠50mg口服溶液,头痛消退。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Status Migrainosus in Children and Adults
According to the International Classification of Headache Disorders, 3rd edition (ICHD-3), status migrainosus (SM) is “a debilitating migraine attack lasting for more than 72 hours.” Analogous to the term “status epilepticus,” “status migrainosus” was coined by Taverner in 1975, used by Lance in 1978, and was first added to the International Classification of Headache Disorders (ICHD-1) in 1988. The condition occurs in those with migraine with or without aura and, aside from increased duration and severity, has features similar to the individual's prior migraine attacks. While attacks should last greater than 72 hours to fulfill the diagnostic criteria for SM (Table 1), short periods of remission (less than 12 hours) due to medication or sleep are accepted. CASE HISTORY This is a 31-year-old woman with a history of migraine without aura for 5 years occurring twice a month lasting 1-2 hours after taking 10 mg of rizatriptan. She presented to the office with an exactly similar nonmenstrual headache continuously occurring for 5 days associated with increased stress and lack of sleep. The headache is described as a generalized, especially bifrontal-temporal, throbbing pain associated with nausea, light and noise sensitivity but no vomiting or aura. Pain intensity was initially 3/10 and since onset has been ranging from 3-8/10; at presentation to the office, her headache severity was 7/10. She had tried rizatriptan, ibuprofen, and a combination of acetaminophen (APAP) /aspirin/caffeine for the past 4 days without help. Past medical history was negative. Neurological exam was normal and she denied any recent illness, trauma, or change in medications. She was given bilateral greater occipital nerve (GON) blocks with 3 cc each and bilateral auriculotemporal, supraorbital, and supratrochlear nerve blocks with 0.5 cc each of 1% lidocaine, as well as diclofenac sodium 50 mg oral solution with resolution of the headache.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
American Headache Society 66th Annual Scientific Meeting June 13–16, 2024 San Diego, California A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open‐label extension Narrative review of peripheral nerve blocks for the management of headache The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition Migraine with aura associates with a higher artificial intelligence: ECG atrial fibrillation prediction model output compared to migraine without aura in both women and men
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1